Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D3 receptor deficient mice

Neuropsychopharmacology

Volumn 24, Issue 2, 2001, Pages 170-182

  Betancur, Catalina ^a,d   Lépée Lorgeoux, Isabelle ^a   Cazillis, Michèle ^a   Accili, Domenico ^b   Fuchs, Sara ^c   Rostène, William ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d INSERM   (France)

Author keywords

Amphetamine; Behavioral sensitization; Cocaine; Dopamine D3 receptor; Haloperidol; In situ hybridization; Neurotensin

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE 3 RECEPTOR; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; NEUROTENSIN; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; LOCOMOTION; MALE; MOUSE; MUTANT; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL;

EID: 0035203754     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00179-2     Document Type: Article

References (62)

1. 3 dopamine receptor gene is associated with hyperactivity in mice
2. Distribution of neurotensin/neuromedin N mRNA in rat forebrain; Unexpected abundance in hippocampus and subiculum
3. 2 receptor antagonists on proneurotensin mRNA expression in rat striatum
4. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum; A detailed cellular co-expression study
5. Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum
6. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine
7. 3 receptor expression as a mechanism of behavioral sensitization to levodopa
8. 3 knock-out and wild-type mice
9. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors
10. Modulation of the neurotensin striato-nigral pathway by D1 receptors
11. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment
12. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens
13. 3 receptor in the rat brain
14. Neurotensin blocks certain amphetamine-induced behaviours
15. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations
16. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients
17. Neurotensin self-injection in the ventral tegmental area
18. Neurotensin; A new 'reward peptide'
19. Response by the neurotensin systems of the basal ganglia to cocaine treatment
20. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists; Relevance to cocaine sensitization
21. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability
22. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization
23. 3 receptors
24. 3 receptors
25. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area
26. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens
27. The neurobiology of neurotensin; Focus on neurotensin-dopamine interactions
28. Does neurotensin mediate the effects of antipsychotic drugs?
29. The rat gene encoding neurotensin and neuromedin N
30. 3 receptor mutant mice
31. Drugs of abuse; Anatomy, pharmacology and function of reward pathways
32. 3 dopamine receptors in the brains of several mammalian species
33. 3 dopamine receptors in rat brain and pituitary gland; A quantitative autoradiographic study
34. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons
35. Coping and the stress-induced potentiation of stimulant stereotypy in the rat
36. Changes in the limbic neurotensin systems induced by dopaminergic drugs
37. 2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain
38. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum
39. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics
40. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine; Comparison with acute haloperidol effects
41. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions
42. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs; role of dopamine D2 and D3 receptors
43. Neurotensin; Perchance an endogenous neuroleptic?
44. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
45. 3 agonist
46. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rat; Opposite and synergistic functional interactions
47. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat
48. The D3 dopamine receptor in cellular and organismal function
49. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities
50. Molecular mechanisms of drug reinforcement and addiction
51. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder
52. 2 receptor antagonist
53. Neurotensin induces catalepsy in mice
54. 3) as a target for neuroleptics
55. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities
56. 1 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens
57. Repeated intravenous cocaine administration; Locomotor activity and dopamine D2/D3 receptors
58. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients; Normalization after neuroleptic treatment
59. 2-type contributions to psychomotor sensitization and reward; Implications for pharmacological treatment strategies
60. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors
61. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat; Light and electron microscopy